2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-09-01 Sage Accounts Production Advanced 2025 - FRS102_2025 12,000 12,000 8,648 2,690 11,338 5,872 999 6,871 4,467 2,776 xbrli:pure xbrli:shares iso4217:GBP SC543653 2024-09-01 2025-08-31 SC543653 2025-08-31 SC543653 2024-08-31 SC543653 2023-09-01 2024-08-31 SC543653 2024-08-31 SC543653 2023-08-31 SC543653 bus:LeadAgentIfApplicable 2024-09-01 2025-08-31 SC543653 bus:Director1 2024-09-01 2025-08-31 SC543653 core:NetGoodwill 2025-08-31 SC543653 core:WithinOneYear 2025-08-31 SC543653 core:WithinOneYear 2024-08-31 SC543653 core:ShareCapital 2025-08-31 SC543653 core:ShareCapital 2024-08-31 SC543653 core:RetainedEarningsAccumulatedLosses 2025-08-31 SC543653 core:RetainedEarningsAccumulatedLosses 2024-08-31 SC543653 bus:SmallEntities 2024-09-01 2025-08-31 SC543653 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 SC543653 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 SC543653 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 SC543653 bus:FullAccounts 2024-09-01 2025-08-31 SC543653 core:NetGoodwill 2024-09-01 2025-08-31 SC543653 core:ComputerEquipment 2024-09-01 2025-08-31 SC543653 core:ComputerEquipment 2024-08-31 SC543653 core:ComputerEquipment 2025-08-31 SC543653 core:OtherRelatedParties 2024-09-01 2025-08-31
COMPANY REGISTRATION NUMBER: SC543653
Gerard McGowan Ophthalmic Consultants Ltd
Filleted Unaudited Financial Statements
31 August 2025
Gerard McGowan Ophthalmic Consultants Ltd
Financial Statements
Year ended 31 August 2025
Contents
Page
Chartered accountants report to the board of directors on the preparation of the unaudited statutory financial statements
1
Statement of financial position
2
Notes to the financial statements
3
Gerard McGowan Ophthalmic Consultants Ltd
Chartered Accountants Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of Gerard McGowan Ophthalmic Consultants Ltd
Year ended 31 August 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Gerard McGowan Ophthalmic Consultants Ltd for the year ended 31 August 2025, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of ICAS, we are subject to its ethical and other professional requirements which are detailed at www.icas.com/accountspreparationguidance. This report is made solely to the Board of Directors of Gerard McGowan Ophthalmic Consultants Ltd, as a body. Our work has been undertaken solely to prepare for your approval the financial statements of Gerard McGowan Ophthalmic Consultants Ltd and state those matters that we have agreed to state to you, as a body, in this report in accordance with the requirements of ICAS as detailed at www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Gerard McGowan Ophthalmic Consultants Ltd and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that Gerard McGowan Ophthalmic Consultants Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Gerard McGowan Ophthalmic Consultants Ltd. You consider that Gerard McGowan Ophthalmic Consultants Ltd is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of Gerard McGowan Ophthalmic Consultants Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
GILLILAND & COMPANY Chartered Accountants
216 West George Street Glasgow G2 2PQ
21 August 2026
Gerard McGowan Ophthalmic Consultants Ltd
Statement of Financial Position
31 August 2025
2025
2024
Note
£
£
£
Fixed assets
Tangible assets
6
4,467
2,776
Current assets
Debtors
7
609,400
307,817
Cash at bank and in hand
89,141
232,786
---------
---------
698,541
540,603
Creditors: amounts falling due within one year
8
249,888
216,720
---------
---------
Net current assets
448,653
323,883
---------
---------
Total assets less current liabilities
453,120
326,659
---------
---------
Net assets
453,120
326,659
---------
---------
Capital and reserves
Called up share capital
100
100
Profit and loss account
453,020
326,559
---------
---------
Shareholders funds
453,120
326,659
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 21 August 2026 , and are signed on behalf of the board by:
Dr G F McGowan
Director
Company registration number: SC543653
Gerard McGowan Ophthalmic Consultants Ltd
Notes to the Financial Statements
Year ended 31 August 2025
1. General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 216 West George Street, Glasgow, G22PQ, Scotland.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill
-
3 Years
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Office Equipment
-
25% reducing balance
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
5. Intangible assets
Goodwill
£
Cost
At 1 September 2024 and 31 August 2025
12,000
--------
Amortisation
At 1 September 2024 and 31 August 2025
12,000
--------
Carrying amount
At 31 August 2025
--------
At 31 August 2024
--------
6. Tangible assets
Equipment
Total
£
£
Cost
At 1 September 2024
8,648
8,648
Additions
2,690
2,690
--------
--------
At 31 August 2025
11,338
11,338
--------
--------
Depreciation
At 1 September 2024
5,872
5,872
Charge for the year
999
999
--------
--------
At 31 August 2025
6,871
6,871
--------
--------
Carrying amount
At 31 August 2025
4,467
4,467
--------
--------
At 31 August 2024
2,776
2,776
--------
--------
7. Debtors
2025
2024
£
£
Trade debtors
59,363
40,541
Amounts owed by group undertakings and undertakings in which the company has a participating interest
457,627
214,340
Other debtors
92,410
52,936
---------
---------
609,400
307,817
---------
---------
8. Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
245,840
214,353
Social security and other taxes
66
27
Other creditors
3,982
2,340
---------
---------
249,888
216,720
---------
---------
9. Holding company
On the 23rd July 2021 the shares in the company were transferred to Emod Investments Limited and the company is now a wholly owned subsidiary of that company. Emod Investments Limited is controlled by Mr and Mrs McGowan.
10. Directors' advances, credits and guarantees
As at 31 August 2025 Dr G F McGowan , a director, owed the company £90,148 (2024: £48,412). Interest has been calculated on this loan and has no fixed date for repayment.
11. Related party transactions
Included in debtors there is a balance owed from the parent company, EMOD Investments Limited, for £457,627 (2024: £214,340).